Member Info for CityWatcher

My advice comes along with some facts about this medical company and their prospects.

Most of the buyers are already holders, and so are topping up. Any price below 10p is a bargain as others have posted.

Futura Medical is another classic example of a company with big prospects now too, but Genedrive could well exceed Futura in wealth from yesterday's (all of a sudden & welcome GREAT NEWS. )

So as it was only 4.69m shares to add.

Following Admission the Company's issued share capital will consist of 143,141,481 Ordinary Shares of 1.5p

Should make for an interesting following week and a half onwards.

You did well, I also have some near that price, however also at 75p in Dec. 21. Ouch !

Bound to be some serious discussion having seen & realised the news overseas. These are likely to take off now with some large trades from America. They also would be buying very close to the bottom price. You only have to look at their graph.

Apologies re a slightly mixed up statement in £'s.

These are more exact.

· Revenue was £24.6 million (January 2023: £1.7m) reflecting receipt of £15.9 million from sale of Orexin-1 receptor antagonist programme and $11 million milestone payment from AstraZeneca.

· Total profit after tax of £17.8 million or 7.06 pence per share (January 2023: loss of £3.9m or 1.55 pence per share).

· R&D expenses remained at £5.2 million (January 2023: £5.2m), reflecting focused investment in key drug discovery programmes focused on immune-inflammatory diseases.

· Net assets of £24.6 million (January 2023: £13.6m).

· Net cash as at 31 January 2024: £13.1 million (31 January 2023: £9.6m), before post-period receipt of $11 million milestone payment from AstraZeneca in February 2024.

The talk of maybe delisting is just a proposal at the moment. The shares will probably still be allowed to trade direct with this company for up to a year as they stated.

So it's not really a reason to panic yet, they seem to be making money too. Cash of £17m approx.

Dr Clive Dix, CEO of C4X Discovery, said: "We have not taken this decision lightly, however, following an extensive review and deliberation to ascertain the most effective way to maximise Shareholder value in the longer term and increase the potential for the long-term success of the Company, the Board has unanimously concluded that it is in the best interests of the Company and our Shareholders to delist from AIM and re-register as a private limited company.

C4X has a successful track record of out-licensed pre-clinical assets to world-leading pharmaceutical companies. The Company has signed three deals which have in total generated $55 million to date demonstrating its scientific and deal-making capabilities:

· In November 2022, AstraZeneca signed a world-wide exclusive agreement worth up to $400 million for C4XD's NRF2 Activator programme; the first milestone payment of $11 million was received in February 2024.

· In April 2021, Sanofi signed a world-wide exclusive agreement for the Company's oral pre-clinical IL-17A inhibitor programme worth up to ?414 million; the first milestone payment of ?3 million was received in July 2022.

· In March 2018, Indivior signed a licensing agreement for C4XD's Orexin-1 Receptor Antagonist Programme which it subsequently acquired in July 2023 for £15.95 million.

Might be interested in the recent update by a knowledgeable robot.

'' Indeed! The takeover of Pendragon by Lithia Motors, which was agreed upon in October 2023, is now approaching its finalization. As per the management’s promise, the completion of this significant transaction is imminent. Shareholders can look forward to the culmination of this deal in the near future. 🚗 ''

There was a special dividend plus shares in The Pinewood Group agreed by the takeover.

2024 it promises to be good. The mines have been in full operation. Plenty of wealth in Griffin Mining now.

Https://edition.pagesuite.com/html5/reader/production/default.aspx?pubname=&edid=d5300e2e-8775-44d8-876a-ddc7b6427f4d

So LGEN are talking about this sale and are keen to maximise value for their shareholders should be able to offload This UK's house building group.

Their finance and asset management group is said to be in talks with bankers at Rothschild to oversee this sale.

May well be valued at around £1bn.

Pleasing news that reeled much buying & now the threat of the fundraise around 4p - 5p approx.

Although I still hold, I don't think it's been fair to the recent investors. Some bought near to double today's price or 70% up on it as it currently stands.

Much buying today and I won't be surprised if total trades top 400. Their latest contract announced 8th, worth over US$200m over 3 years for a Turkmenistan gas field is the reason the share will be more in demand for recovery play. Believe 22.5p approx. will be the lowest we see Petrofac before the upside that is expected now. Seems to have started.

Your 2.65p was about the price that many investors top sliced or sold a chunk of shares at whilst fearing what would happen following their suspension that had been announced 'was happening' . Funding was an issue then plus GCM were still awaiting The Bangladesh Government to decide on what to do regarding their countries energy crisis. No decision by their government has been voiced yet. Very slow here !

How rich are they !

You bet The Bangladesh Government will take their time deciding whether to press the green button.

Can see this around the 6p price over the next couple of weeks. However I'm still holding. Maybe new investors should be careful as has been suggested already.

Hopefully as already mentioned Kier to join the Footsie 250 very soon. They also report in 5 trading days - March 7th and are meant to be re-instating their dividend, so exciting times ahead.

What a great idea. Happening now in Sheffield and Nottingham they said.

Day Fever Clubs for Afternoon Partying. Will likely catch on in London too, if not already !

Yea & it's only 2 weeks today to await their report which has promised to be spectacular as follows ............................

Kier said its strong trading performance, secure order book and improved balance sheet instilled confidence in the board to reinstate dividend payments in the current financial year.

The resumption was set to start with an interim dividend coinciding with the release of its half-year results.

"Kier has made a good start to the year, in line with our expectations," said chief executive officer Andrew Davies.

Funds was the issue when I knew I should be buying more. But I also want to top up at below 40p, but doubt you will get your 36p wish. There will be a frenzy of buying if they drop that much.

Correct with your guess. Their income on the gold pour haul to be less than $100k.

Cascabel is still very much sought after. Link was from early Dec.2023

https://www.globalminingreview.com/mining/05122023/solgold-discovers-silver-and-gold-at-ecuador-project/